Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Pharmaceutical Statistics|August 4, 2021
Counterfactual mediation analysis in the multistate model framework for surrogate and clinical time-to-event outcomes in randomized controlled trialsIsabelle R Weir, Jennifer R Rider, Ludovic TrinquartEuropean Urology|April 30, 2019
Restricted Mean Survival Times to Improve Communication of Evidence from Cancer Randomized Trials and Observational StudiesLudovic Trinquart, Anna Bill-Axelson, Jennifer R RiderCancer Causes & Control : CCC|November 6, 2015
Metformin and prostate cancer mortality: a meta-analysisKonrad H Stopsack, David R Ziehr, Jennifer R Rider, et al.Cancer|November 27, 2019
Impact of age at diagnosis of de novo metastatic prostate cancer on survivalBrandon Bernard, Colin Burnett, Christopher J Sweeney, et al.European Urology|August 21, 2012
Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based studyJennifer R Rider, Fredrik Sandin, Ove Andrén, et al.Urologic Oncology|November 7, 2020
Disparities in precision medicine-Examining germline genetic counseling and testing patterns among men with prostate cancerHala T Borno, Anobel Y Odisho, Christine M Gunn, et al.Journal of the National Cancer Institute|July 28, 2012
Temporal trends in cause of death among Swedish and US men with prostate cancerMara M Epstein, Gustaf Edgren, Jennifer R Rider, et al.The Prostate|January 29, 2016
Trichomonas vaginalis infection and risk of advanced prostate cancerIrene M Shui, Suzanne Kolb, Christi Hanson, et al.Cancer Causes & Control : CCC|July 3, 2019
Socioenvironmental adversity and risk of prostate cancer in non-Hispanic black and white menElizabeth D Kantor, Sebastien Haneuse, Unnur A Valdimarsdóttir, et al.European Urology|April 2, 2016
Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-upJennifer R Rider, Kathryn M Wilson, Jennifer A Sinnott, et al.Pageof 7